Potential role of differential medication use in explaining excess risk of cardiovascular events and death associated with chronic kidney disease: A cohort study
<p>Abstract</p> <p>Background</p> <p>Patients with chronic kidney disease (CKD) are less likely to receive cardiovascular medications. It is unclear whether differential cardiovascular drug use explains, in part, the excess risk of cardiovascular events and death in pat...
Main Authors: | Fortmann Stephen P, Iribarren Carlos, Chandra Malini, Hsu Chi-yuan, Bansal Nisha, Hlatky Mark A, Go Alan S |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-09-01
|
Series: | BMC Nephrology |
Online Access: | http://www.biomedcentral.com/1471-2369/12/44 |
Similar Items
-
Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study
by: Sarah J. Schrauben, et al.
Published: (2019-02-01) -
Death and cardiovascular events after bacteriuria among adult women with chronic kidney disease
by: Dhanyamraju S, et al.
Published: (2012-11-01) -
Hypertension, cardiovascular disease and cause of death in Danish living kidney donors: matched cohort study
by: Lars Køber, et al.
Published: (2020-11-01) -
Risk of Kidney Failure, Death, and Cardiovascular Events After Lower Limb Complications in Patients With CKD
by: Kevin Li, et al.
Published: (2021-02-01) -
Racial variation in lipoprotein-associated phospholipase A<sub>2 </sub>in older adults
by: Go Alan S, et al.
Published: (2011-06-01)